# TherapeuticsMD (TXMD) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/TXMD
## Company Profile
- Ticker: TXMD
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Women's Health
## Stock Data
- Close: 2.09 USD
- Market cap: 23611698.48 USD
- Last updated: 2026-08-06
## Business Overview
### Pharmaceutical Royalty Company
TherapeuticsMD owns rights to royalties and license revenue from women’s health pharmaceutical products rather than operating a broad internal commercial organization.
### Royalty Portfolio Model
Revenue is primarily tied to products licensed under the Mayne agreement, giving TherapeuticsMD exposure to partner sales without directly funding commercialization. The business focuses on collecting contractual economics and preserving remaining intellectual property rights.
## Why The Stock Is Moving

As of Aug 6, 2026, TXMD closed up 0.97% at $2.09. No new same-company headline was identified in the current news window.

## Future Catalysts

- TherapeuticsMD is now largely a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update. The market no longer treats it like an active growth name.

## Recent News
- 2026-05-12 20:05 EST — [TherapeuticsMD Announces First Quarter 2026 Financial Results](https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-first-quarter-2026-financial-results) — Source: TherapeuticsMD
- 2026-03-30 20:05 EST — [TherapeuticsMD Announces Full Year 2025 Financial Results](https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-full-year-2025-financial-results) — Source: TherapeuticsMD
- 2025-11-12 21:05 EST — [TherapeuticsMD Announces Third Quarter 2025 Financial Results](https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-third-quarter-2025-financial-results) — Source: TherapeuticsMD
- 2025-08-12 20:05 EST — [TherapeuticsMD Announces Second Quarter 2025 Financial Results](https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-second-quarter-2025-financial-results) — Source: TherapeuticsMD
- 2025-05-13 20:05 EST — [TherapeuticsMD Announces First Quarter 2025 Financial Results](https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-first-quarter-2025-financial-results) — Source: TherapeuticsMD
